Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can ...

The first step in the development of such an assay was provided by the isolation and characterization of a set of 41 cosmid, P1 and PAC clones specific for all human subtelomeric chromosome ...